Cysticercose (Taenia solium)
Adviezen
Prioriteit | Medicatie | Opmerking |
---|---|---|
Prioriteit: 1e keus |
Medicatie: albendazol po 7.5mg/kg 2dd 10 dagen +
praziquantel po 25mg/kg 2dd 10 dagen |
Opmerking:
Indien medicamenteuze behandeling voor patienten met 3 of meer parenchymale cysten (max. 1200 mg albendazol/dag) |
Prioriteit: 1e keus |
Medicatie: albendazol po 7.5mg/kg 2dd 10 dagen |
Opmerking:
Bij medicamenteuze therapie voor patienten met 1 of 2 parenchymale cysten (max. 1200 mg albendazol/dag) |
Bronnen
-
Pubmed.gov publication # 24999157
Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, Saavedra H, Gavidia M, Rodriguez L, Najar E, Umeres H, Pretell EJ; Cysticercosis Working Group in Peru. 2014 Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014 Aug;14(8):687-95
-
Pubmed.gov publication # 23568997
Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL (2013) Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 80(15):1424-9
-
Pubmed.gov publication # 23269591
Otte WM, Singla M, Sander JW, Singh G. (2013) Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurology. 80(2):152-62
-
Pubmed.gov publication # 29644966
White, A.C. et al. 2018 Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg 98:945-966.
Antimicrobiële middelen
De volgende antimicrobiele middelen zijn verwerkt in deze adviezen:
Externe referenties
Categorie
Metadata
Swab vid: G-147003.10
Bijgewerkt: 02/05/2024 - 16:02
Status: Published
Algemene opmerkingen